Chemours Company Faces Securities Class Action Over Opteon Demand Claims
Chemours Company faces a securities class action lawsuit alleging misleading statements regarding Opteon aftermarket demand by executives. Eligible investors purchasing shares during the specified per
PR Newswire · 2026-10-29 14:59